U.S. task force recommends against routine PSA screening for prostate cancer

TORONTO - Routinely screening men for prostate cancer with PSA tests can result in far more harm than good, says a U.S. expert panel in a recommendation against the practice that is sure to fuel continued debate over the issue.

U.S. task force: End routine prostate cancer screening

NEW YORK (Reuters) - A task force advising the U.S. government on Monday recommended against routine use of the prostate-cancer screening test called PSA, or prostate specific antigen, for lack of a discernible health benefit. Like a draft proposal last October, the U.S. Preventive Services Task Force gave PSA screening a D, for "don't recommend" in healthy men. The reaction was fast and furious ...